Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	CP2	TFCP2L1 TFCP2	9.64e-05	6	48	2	PF04516
Domain	CP2	TFCP2L1 TFCP2	9.64e-05	6	48	2	IPR007604
Domain	C2	PRF1 HECW2 RIMS1	4.63e-03	131	48	3	PF00168
Domain	C2	PRF1 HECW2 RIMS1	5.25e-03	137	48	3	SM00239
Domain	C2	PRF1 HECW2 RIMS1	5.80e-03	142	48	3	PS50004
Domain	WW	HECW2 UTRN	6.49e-03	47	48	2	PF00397
Domain	-	PRF1 HECW2 RIMS1	6.50e-03	148	48	3	2.60.40.150
Domain	WW	HECW2 UTRN	6.77e-03	48	48	2	SM00456
Domain	WW_DOMAIN_2	HECW2 UTRN	7.61e-03	51	48	2	PS50020
Domain	WW_DOMAIN_1	HECW2 UTRN	7.61e-03	51	48	2	PS01159
Domain	WW_dom	HECW2 UTRN	7.90e-03	52	48	2	IPR001202
Domain	C2_dom	PRF1 HECW2 RIMS1	8.61e-03	164	48	3	IPR000008
Domain	-	TRPS1 NR1D1	9.43e-03	57	48	2	3.30.50.10
Domain	Znf_NHR/GATA	TRPS1 NR1D1	9.76e-03	58	48	2	IPR013088
Pathway	REACTOME_SIGNALING_BY_KIT_IN_DISEASE	JAK2 KRAS PIK3R3	1.69e-05	20	36	3	M39002
Pathway	REACTOME_SIGNALING_BY_SCF_KIT	JAK2 KRAS PIK3R3	1.12e-04	37	36	3	MM14564
Pathway	REACTOME_SIGNALING_BY_SCF_KIT	JAK2 KRAS PIK3R3	1.76e-04	43	36	3	M508
Pathway	PID_ERBB2_ERBB3_PATHWAY	JAK2 KRAS PIK3R3	1.89e-04	44	36	3	M175
Pathway	WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER	KRAS PIK3R3 TSC1	2.76e-04	50	36	3	M39822
Pubmed	CRTR-1, a developmentally regulated transcriptional repressor related to the CP2 family of transcription factors.	TFCP2L1 TFCP2	1.94e-06	2	49	2	11073954
Pubmed	Modulation of CP2 family transcriptional activity by CRTR-1 and sumoylation.	TFCP2L1 TFCP2	1.94e-06	2	49	2	20661472
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	JAK2 EPS15L1 DCAF8 PIK3R3 NAT10 TRPS1 LMBR1 RASEF RIMS1 UTRN SCARA3	5.54e-06	1489	49	11	28611215
Pubmed	TFCP2/TFCP2L1/UBP1 transcription factors in cancer.	TFCP2L1 TFCP2	5.83e-06	3	49	2	29410248
Pubmed	False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.	JAK2 KRAS	5.83e-06	3	49	2	29567812
Pubmed	Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations.	JAK2 KRAS	5.83e-06	3	49	2	25105841
Pubmed	TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.	KRAS TSC1	5.83e-06	3	49	2	19966866
Pubmed	A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.	KRAS EPRS1 ADAMTSL5 ZNF584 ABCB5 RIMS1	7.04e-06	331	49	6	19490893
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	EPRS1 EPS15L1 DCAF8 ZNF584 TRPS1 BRCC3 DZIP1 ZNF439 NR1D1 UTRN	1.01e-05	1285	49	10	35914814
Pubmed	Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer.	JAK2 KRAS	1.16e-05	4	49	2	26575024
Pubmed	Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.	KRAS TSC1	1.16e-05	4	49	2	16267007
Pubmed	The Janus kinase 1 is critical for pancreatic cancer initiation and progression.	JAK2 KRAS	1.94e-05	5	49	2	38733583
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SEPTIN8 EPRS1 EPS15L1 HECW2 TSC1 RIMS1 UTRN JMY ADD1 NUAK2	2.56e-05	1431	49	10	37142655
Pubmed	The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.	KRAS TSC1	2.91e-05	6	49	2	21941369
Pubmed	Identification and characterization of Grainyhead-like epithelial transactivator (GET-1), a novel mammalian Grainyhead-like factor.	TFCP2L1 TFCP2	2.91e-05	6	49	2	12666198
Pubmed	The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination.	JAK2 BRCC3	4.07e-05	7	49	2	30755420
Pubmed	Deregulated Notch and Wnt signaling activates early-stage myeloid regeneration pathways in leukemia.	JAK2 KRAS	4.07e-05	7	49	2	31886826
Pubmed	Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK.	JAK2 PIK3R3	4.07e-05	7	49	2	9178903
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EPRS1 EPS15L1 NAT10 TSC1 UTRN DIS3 TFCP2 ADD1	4.46e-05	934	49	8	33916271
Pubmed	TFCP2 Is Required for YAP-Dependent Transcription to Stimulate Liver Malignancy.	NR1D1 TFCP2	5.42e-05	8	49	2	29091762
Pubmed	BioID-based proteomic analysis of the Bid interactome identifies novel proteins involved in cell-cycle-dependent apoptotic priming.	EPRS1 EPS15L1 NAT10	6.55e-05	55	49	3	33067418
Pubmed	Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias.	JAK2 KRAS	6.96e-05	9	49	2	19865112
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEPTIN8 HECW2 NAT10 DZIP1 DIS3 NUAK2	9.67e-05	529	49	6	14621295
Pubmed	Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer.	KRAS TRPS1	1.06e-04	11	49	2	34475389
Pubmed	DNA cloning using in vitro site-specific recombination.	NAT10 ENTPD6 LMBR1 BRCC3 ADAM11 TIMMDC1 NUAK2	1.17e-04	794	49	7	11076863
Pubmed	Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.	JAK2 KRAS	1.27e-04	12	49	2	20678218
Pubmed	ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.	JAK2 KRAS	1.50e-04	13	49	2	20880116
Pubmed	The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.	KRAS ABCB5 TSC1	2.00e-04	80	49	3	28205554
Pubmed	RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies	JAK2 KRAS	2.61e-04	17	49	2	33661592
Pubmed	CEBPA-Associated Familial Acute Myeloid Leukemia (AML)	JAK2 KRAS	2.61e-04	17	49	2	20963938
Pubmed	ETV6 Thrombocytopenia and Predisposition to Leukemia	JAK2 KRAS	2.61e-04	17	49	2	33226740
Pubmed	Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1.	KRAS DCAF8	2.93e-04	18	49	2	31257023
Pubmed	DDX41-Associated Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia	JAK2 KRAS	2.93e-04	18	49	2	34723452
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	PIK3R3 TBC1D22B DZIP1 UTRN ADD1	3.12e-04	421	49	5	36976175
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	SEPTIN8 EPS15L1 RIMS1 ADD1	3.18e-04	231	49	4	16452087
Pubmed	Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph.	KRAS PRF1 TSC1 TIMMDC1	3.18e-04	231	49	4	21048031
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	EPS15L1 DCAF8 ZNF584 TRPS1 DIS3 TFCP2	4.01e-04	689	49	6	36543142
Pubmed	Interaction proteomics of canonical Caspr2 (CNTNAP2) reveals the presence of two Caspr2 isoforms with overlapping interactomes.	KCNA6 ADAM11	4.01e-04	21	49	2	25707359
Pubmed	The LIFEdb database in 2006.	NAT10 ENTPD6 LMBR1 BRCC3 TIMMDC1 NUAK2	5.06e-04	720	49	6	16381901
Pubmed	From ORFeome to biology: a functional genomics pipeline.	NAT10 ENTPD6 LMBR1 BRCC3 TIMMDC1 NUAK2	5.13e-04	722	49	6	15489336
Pubmed	Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.	JAK2 KRAS	5.71e-04	25	49	2	8493579
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	SEPTIN8 EPS15L1 UTRN	7.40e-04	125	49	3	29467281
Pubmed	LZTR1 is a regulator of RAS ubiquitination and signaling.	KRAS SEPTIN8 ADD1	7.75e-04	127	49	3	30442766
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	EPRS1 RIMS1 ADD1	7.93e-04	128	49	3	30995482
Pubmed	Multiple loci are associated with white blood cell phenotypes.	EPS15L1 NR1D1	9.98e-04	33	49	2	21738480
Pubmed	A genome-wide association study (GWAS) for bronchopulmonary dysplasia.	TRPS1 FTMT	1.06e-03	34	49	2	23897914
Pubmed	Genome-wide association study of selenium concentrations.	JMY TTLL7	1.12e-03	35	49	2	25343990
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SRPK3 BRCC3 TBC1D22B DZIP1 UTRN NUAK2	1.28e-03	861	49	6	36931259
Interaction	BACH1 interactions	JAK2 DCAF8 ASAP3 BRCC3 NR1D1	6.56e-06	111	48	5	int:BACH1
Coexpression	FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	TFCP2L1 PRF1 ENTPD6 TSC1	1.53e-06	46	48	4	M2161
Coexpression	THUM_SYSTOLIC_HEART_FAILURE_UP	JAK2 VSIG4 LMBR1 BRCC3 NR1D1 UTRN SCARA3	1.26e-05	430	48	7	M3654
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN	PIK3R3 NAT10 TSC1 BRCC3 ADD1	3.15e-05	199	48	5	M7711
Coexpression	GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	SEPTIN8 TSC1 DZIP1 JMY ADD1	3.23e-05	200	48	5	M7525
ToppCell	3'_v3-bone_marrow-Mast-Mast_cell_lympho\|bone_marrow / Manually curated celltypes from each tissue	SEPTIN8 EPS15L1 ZNF439 PCDH9 TTLL7	1.21e-06	170	49	5	4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15
ToppCell	facs-Brain_Non-Myeloid\|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEPTIN8 NR1D1 UTRN PCDH9 TTLL7	2.49e-06	197	49	5	a1f7eec1aca03432caa8fe817ff6d24b29d4062d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF584 PIK3R3 VSIG4 NR1D1	2.42e-05	153	49	4	ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF584 PIK3R3 VSIG4 NR1D1	2.42e-05	153	49	4	90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF584 PIK3R3 VSIG4 NR1D1	2.42e-05	153	49	4	a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	RIMS1 UTRN SCARA3 TTLL7	2.88e-05	160	49	4	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	RIMS1 UTRN SCARA3 TTLL7	2.95e-05	161	49	4	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TFCP2L1 RIMS1 DZIP1 PCDH9	4.97e-05	184	49	4	d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TFCP2L1 RIMS1 DZIP1 PCDH9	4.97e-05	184	49	4	8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b
ToppCell	NS-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TFCP2L1 PIK3R3 RASEF RIMS1	5.18e-05	186	49	4	c28f62524637c7eb9c43c9ec38fb12dfec6f5566
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRF1 TBC1D22B DZIP1 UTRN	5.18e-05	186	49	4	4dce1484653bb266e2305cbb306fb11eaf7892e2
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRF1 TBC1D22B DZIP1 UTRN	5.18e-05	186	49	4	e23e1246914e230369a716d0d666b98383bf8512
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TFCP2L1 SPDYA DZIP1 PCDH9	5.51e-05	189	49	4	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TFCP2L1 SPDYA DZIP1 PCDH9	5.51e-05	189	49	4	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TFCP2L1 RIMS1 DZIP1 PCDH9	5.51e-05	189	49	4	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	facs-Brain_Non-Myeloid-Cortex\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEPTIN8 KCNA6 PCDH9 ADD1	6.35e-05	196	49	4	256fe9bc0815f66a9afe11ba3507ef1372b52fd3
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; PC3; HT_HG-U133A	PRF1 AVIL PIK3R3 NR1D1 SCARA3 NUAK2	4.11e-06	198	49	6	3730_DN
Drug	zinc telluride	FTMT TFCP2	2.71e-05	4	49	2	CID003362486
Drug	Cyclosporin C	ABCB5 SCARA3	4.52e-05	5	49	2	CID005287817
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; PC3; HT_HG-U133A	JAK2 EPS15L1 PCDHGA1 RIMS1 ADAM11	6.00e-05	194	49	5	4624_UP
Drug	Niflumic acid [4394-00-7]; Down 200; 14.2uM; PC3; HT_HG-U133A	KRAS ASAP3 DZIP1 UTRN TTLL7	6.30e-05	196	49	5	5071_DN
Drug	prednisolone; Down 200; 1uM; MCF7; HG-U133A	DCAF8 VSIG4 SCARA3 DIS3 TTLL7	6.30e-05	196	49	5	265_DN
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	JAK2 EPS15L1 TFCP2L1 PRF1 NR1D1	6.45e-05	197	49	5	3800_DN
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	EPS15L1 ASAP3 RIMS1 NR1D1 UTRN	6.45e-05	197	49	5	3316_UP
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	JAK2 NAT10 ASAP3 DZIP1 SCARA3	6.45e-05	197	49	5	3752_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; HL60; HT_HG-U133A	KRAS EPS15L1 DZIP1 UTRN NUAK2	6.45e-05	197	49	5	1848_UP
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A	JAK2 EPRS1 PRF1 TFCP2 TTLL7	6.45e-05	197	49	5	2110_UP
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; PC3; HT_HG-U133A	EPS15L1 PRF1 DZIP1 PCDH9 TTLL7	6.61e-05	198	49	5	3676_DN
Drug	Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; PC3; HT_HG-U133A	DCAF8 ASAP3 UTRN SCARA3 TTLL7	6.77e-05	199	49	5	5769_DN
Disease	alcoholic liver cirrhosis (is_marker_for)	JAK2 NR1D1	8.88e-05	9	47	2	DOID:14018 (is_marker_for)
Disease	Pancreatic Ductal Adenocarcinoma	ABCB5 ADAM11	1.35e-04	11	47	2	C1335302
Disease	peripheral arterial disease, traffic air pollution measurement	TRPS1 RASEF RIMS1 UTRN	2.59e-04	194	47	4	EFO_0004265, EFO_0007908
Disease	lateral occipital cortex volume measurement	TRPS1 UTRN	3.33e-04	17	47	2	EFO_0010311
Disease	Acute myeloid leukemia	JAK2 KRAS	3.33e-04	17	47	2	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	JAK2 KRAS	3.33e-04	17	47	2	601626
Disease	colon adenocarcinoma (is_implicated_in)	JAK2 PIK3R3	7.88e-04	26	47	2	DOID:234 (is_implicated_in)
Disease	Crohn's disease (is_implicated_in)	JAK2 PRF1	1.05e-03	30	47	2	DOID:8778 (is_implicated_in)
Disease	intellectual disability (is_implicated_in)	KRAS TSC1	1.05e-03	30	47	2	DOID:1059 (is_implicated_in)
Disease	Acute Myeloid Leukemia, M1	JAK2 KRAS VSIG4	1.05e-03	125	47	3	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	JAK2 KRAS VSIG4	1.05e-03	125	47	3	C1879321
Disease	Uterine Cervical Neoplasm	JAK2 KRAS	1.43e-03	35	47	2	C0007873

Protein segments in the cluster

Peptide	Gene	Start	Entry
HESRQEAHRSLEQYD	EPS15L1	551	Q9UBC2
VTHNRTYHFQAEDEH	ASAP3	366	Q8TDY4
VQHREVQYHESDTFR	AVIL	91	O75366
NVRHYRDHIGVVSQE	ABCB5	456	Q2M3G0
QYVERHFSREGTTQH	ADAM11	111	O75078
NTKSFEDIHHYREQI	KRAS	86	P01116
SEVEYKHQRGFQRSH	RASEF	451	Q8IZ41
VFHIDESTRHNVLYR	JAK2	101	O60674
RIDSHGRIFYVDHVN	HECW2	816	Q9P2P5
RTRIEDEYRTHHTVQ	JMY	641	Q8N9B5
EVSAREQHFHSQVRE	LMBR1	6	Q8WVP7
HIQENEESHYESQRR	PCDH9	1036	Q9HC56
EESHYESQRRVTFHL	PCDH9	1041	Q9HC56
SFHQTYRERHSEVVG	PRF1	291	P14222
HYSINDENRVHDRSE	DCAF8	86	Q5TAQ9
HHQAQETRYEVRIQL	ADAMTSL5	391	Q6ZMM2
DVHSRYRTEAHQDVV	NAT10	166	Q9H0A0
QTFVYSHVHRRDFRE	RIMS1	811	Q86UR5
QVARAHREIFTYAHD	NR1D1	291	P20393
HTQEQHSKEYIERFR	PIK3R3	231	Q92569
TSVREVSEPRHNHFY	IGSF10	956	Q6WRI0
HRETEQEEQGQYTHV	KCNA6	466	P17658
HTHYAQNRTVERFES	SCARA3	331	Q6AZY7
FSRYFLHQSREETEH	FTMT	111	Q8N4E7
EVTYSFHNVDHRVAQ	PCDHGA1	276	Q9Y5H4
FHDDTHSRIEQYATR	UTRN	3186	P46939
VHHSGAVRNYNRDEV	SPDYA	201	Q5MJ70
THALRTTEYHDRDEQ	EPRS1	391	P07814
RNEEHHQDTYRQIHI	TBC1D22B	256	Q9NU19
RIDEQVHNHFRRYEV	TBC1D22B	386	Q9NU19
TQVYHERVNTHVAEA	TMEM151B	191	Q8IW70
NRVHRTEEVKHVDFY	ENTPD6	366	O75354
EARHFFRQIVSAVHY	NUAK2	151	Q9H093
RVVFHDRRLQYTEHQ	TFCP2L1	101	Q9NZI6
YTFTNEHHRETYVEQ	DIS3	121	Q9Y2L1
EHHRETYVEQEQGEN	DIS3	126	Q9Y2L1
HIQRRHTEENSHFEY	DZIP1	216	Q86YF9
VHKHFTEDIQTRQYR	SRPK3	416	Q9UPE1
QEEQDAYRRIHSLTH	BRCC3	241	P46736
YNHITTRVNSEQEHF	ADD1	166	P35611
SSYFRIHERIHTGEQ	ZNF833P	106	Q6ZTB9
QVEEEISRHYRRAHS	TRPS1	676	Q9UHF7
HSQIRQLQHDREEFY	TSC1	776	Q92574
RVVFHDRRLQYTEHQ	TFCP2	121	Q12800
TRDQYATVTHNVHEE	SAGE1	571	Q9NXZ1
EIYHNRFDAVQSAHR	TIMMDC1	111	Q9NPL8
EDLREQTHSRHYELY	SEPTIN8	286	Q92599
SQQEHVYEAARAHAR	VSIG4	311	Q9Y279
RHQQFHTEERSYECT	ZNF584	371	Q8IVC4
YSVNKHNEHFERDET	TTLL7	251	Q6ZT98
RYVQNFRFHERTQTH	ZNF439	476	Q8NDP4
VRHTKRHEEEQVYEQ	PP2D1	46	A8MPX8